These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14392086)

  • 21. [2 Years of campaign in the state of Rio de Janeiro].
    BRANCO FG
    Arq Bras Med Nav; 1958; 19(69):7187-90. PubMed ID: 13584208
    [No Abstract]   [Full Text] [Related]  

  • 22. Leprosy elimination campaign (LEC) in Hodeidah Province, Republic of Yemen, 1997-1998: results and treatment outcome.
    Al Dobai AB; Al Kubati AS; Al Qubati Y
    Lepr Rev; 2004 Mar; 75(1):97-8. PubMed ID: 15072132
    [No Abstract]   [Full Text] [Related]  

  • 23. Characteristics and treatment outcomes of leprosy patients detected during a leprosy elimination campaign in Mozambique compared with routinely detected patients.
    Phaff C; Van Den Broek J; MacArthur A; Ndeve A; Stuip Y
    Lepr Rev; 2003 Sep; 74(3):229-39. PubMed ID: 14577468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leprosy elimination campaign (LEC) in Hodeidah Province, Republic of Yemen, 1997-1998: results and treatment outcome.
    Kawuma HJ
    Lepr Rev; 2004 Dec; 75(4):405. PubMed ID: 15682978
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of the modified leprosy elimination campaign in a high leprosy endemic district of Jharkhand.
    Sekar B; Kothandapani G; Prabhakar Rao T; Krishnamurthy P
    Indian J Lepr; 2003; 75(3):233-42. PubMed ID: 15267193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Organization of antileprosy campaign in the Congo Red Cross zone at Nepoko].
    SWERTS L
    Ann Soc Belg Med Trop (1920); 1954 Oct; 34(5):639-41. PubMed ID: 14362157
    [No Abstract]   [Full Text] [Related]  

  • 27. Can social marketing approaches change community attitudes towards leprosy?
    Brown W
    Lepr Rev; 2006 Jun; 77(2):89-98. PubMed ID: 16895065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An analysis of the pattern of detection of leprosy patients by institutions in the general health services in Sri Lanka after the integration of leprosy services into general health services.
    Wijesinghe PR; Settinayake S
    Lepr Rev; 2005 Dec; 76(4):296-304. PubMed ID: 16411509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Leprosy and the anti-leprosy campaign in Turkey].
    UTKU E
    Maroc Med; 1963 Jul; 42():542-5. PubMed ID: 13995572
    [No Abstract]   [Full Text] [Related]  

  • 30. [A visit to the anti-leprosy organizations and establishments in Nigeria].
    RICOU EP
    J Med (Oporto); 1957 Nov; 34(773):562-4 passim. PubMed ID: 13480761
    [No Abstract]   [Full Text] [Related]  

  • 31. Contribution of mini-LECS to cluster approach case finding in Kaduna State, Nigeria.
    van der Grinten EM; Belel AD
    Lepr Rev; 2006 Jun; 77(2):154-9. PubMed ID: 16895072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The debate over leprosy elimination versus sustainability of leprosy services.
    Indian J Lepr; 2005; 77(4):299-304. PubMed ID: 16465825
    [No Abstract]   [Full Text] [Related]  

  • 33. National Leprosy Eradication Programme and progress towards elimination of leprosy in India.
    Dhillon GP; Barkakaty BN
    J Indian Med Assoc; 2004 Dec; 102(12):674-6. PubMed ID: 15871349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.
    Reid SE; Reid CA; Vermund SH
    Int J STD AIDS; 2004 Nov; 15(11):713-6. PubMed ID: 15537453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WHO global strategy for further reducing the leprosy burden and sustaining leprosy control activities (Plan period: 2006-2010).
    World Health Organization
    Indian J Lepr; 2006; 78(1):7-31. PubMed ID: 16646281
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years.
    Sharma P; Mukherjee R; Talwar GP; Sarathchandra KG; Walia R; Parida SK; Pandey RM; Rani R; Kar H; Mukherjee A; Katoch K; Benara SK; Singh T; Singh P
    Lepr Rev; 2005 Jun; 76(2):127-43. PubMed ID: 16038246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WHO regional strategy for sustaining leprosy services and further reducing the burden of leprosy, 2006-2010.
    WHO Regional Office for South-East Asia
    Indian J Lepr; 2006; 78(1):33-47. PubMed ID: 16646282
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of leprosy using rifampicin as chemoprophylaxis.
    Bakker MI; Hatta M; Kwenang A; Van Benthem BH; Van Beers SM; Klatser PR; Oskam L
    Am J Trop Med Hyg; 2005 Apr; 72(4):443-8. PubMed ID: 15827283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ways for the practical elimination of leprosy in the Rostov oblast.
    GREBENNIKOV PS
    Int J Lepr; 1960; 28():309-13. PubMed ID: 13708121
    [No Abstract]   [Full Text] [Related]  

  • 40. [Secrecy and reportability in leprosy].
    PICARELLI J
    Rev Bras Leprol; 1953 Sep; 21(3):227-44. PubMed ID: 13167566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.